Recent Updates
Recently added Catalysts
ICLR Positive Sentiment Score: 60/100

ICON plc Schedules First Quarter 2023 Earnings Conference Call DUBLIN--(BUSINESS WIRE)

Key Takeaway: ICON plc announced that it will release its first-quarter 2023 financial results on April 26, 2023, after market closure. A conference call to discuss performance will be held on April 27, 2023. The organization emphasizes its major role in clinical research globally and highlights potential risks and uncertainties associated with its operations, including the impact of market conditions and COVID-19.

Market Sentiment Analysis

POSITIVE FACTORS

  • ICON plc is scheduled to report its financial results, indicating ongoing business activity.
  • The company is actively engaging with investors through a scheduled conference call.
  • ICON's presence with a significant workforce across 53 countries suggests a strong operational capacity.

CONCERNS & RISKS

  • The forward-looking statements include uncertainties about future performance.
  • Risks such as the ability to maintain client relationships and potential impacts from COVID-19 are mentioned.

Full Press Release Details

ICON plc Schedules First Quarter 2023 Earnings Conference Call

DUBLIN--(BUSINESS WIRE)--March 29, 2023--ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that it will release its financial results for the first quarter 2023 after
the market closes on Wednesday, April 26, 2023. The company will hold a conference call and webcast to discuss its financial results and performance on Thursday, April 27, 2023 at 8:00am ET.
Any changes to these events and links to the live webcasts (where available) will be posted on the Investor section of our website under "Events". A webcast replay of the conference call will be available approximately one hour following the
conclusion of the call.
ICON plc is a world-leading healthcare intelligence and clinical research organization. From molecule to medicine, we advance clinical research providing outsourced services to pharmaceutical, biotechnology, medical device and government and
public health organizations. We develop new innovations, drive emerging therapies forward and improve patient lives. With headquarters in Dublin, Ireland, ICON employed approximately 41,100 employees in 111 locations in 53 countries as at
December 31, 2022. For further information about ICON, visit: www.iconplc.com.
This press release contains forward-looking statements. These statements are based on management's current expectations and information currently available, including current economic and industry conditions. These statements are not
guarantees of future performance or actual results, and actual results, developments and business decisions may differ from those stated in this press release. The forward-looking statements are subject to future events, risks, uncertainties
and other factors that could cause actual results to differ materially from those projected in the statements, including, but not limited to, the ability to enter into new contracts, maintain client relationships, manage the opening of new
offices and offering of new services, the integration of new business mergers and acquisitions, the impact of COVID-19 on our business, as well as other economic and global market conditions and other risks and uncertainties detailed from time
to time in SEC reports filed by ICON, all of which are difficult to predict and some of which are beyond our control. For these reasons, you should not place undue reliance on these forward-looking statements when making investment decisions.
The word "expected" and variations of such words and similar expressions are intended to identify forward-looking statements. Forward-looking statements are only as of the date they are made and we do not undertake any obligation to update
publicly any forward-looking statement, either as a result of new information, future events or otherwise. More information about the risks and uncertainties relating to these forward-looking statements may be found in SEC reports filed by
ICON, including its Form 20-F, F-1, F-4, S-8, F-3 and certain other reports, which are available on the SEC's website at http://www.sec.gov.

Contacts

Kate Haven Vice President Investor Relations +1888 381 7923

Frequently Asked Questions

When will ICON plc announce its Q1 2023 financial results?

ICON plc will release its Q1 2023 financial results on April 26, 2023.

What time is the ICON plc earnings conference call?

The earnings conference call is scheduled for April 27, 2023, at 8:00am ET.

How can I access the ICON plc conference call webcast?

Links to the webcast will be posted on the Investor section of ICON's website.

When will a replay of the conference call be available?

A replay of the conference call will be available about one hour after it concludes.

What type of organization is ICON plc?

ICON plc is a leading healthcare intelligence and clinical research organization.

Last updated: Mar 29, 2023